Eight years ago, Tom Price, MD, warned how “defensive medicine” drove healthcare costs, estimating 26 cents of every dollar went to unnecessary tests to protect physicians and hospitals from malpractice suits. The estimate wasn’t taken seriously back then, but researchers are now offering an estimate that 5 percent of costs can be attributed to such practices.

On Tuesday, July 24, CMS released a new rule that will allow risk-adjustment payments, which were halted July 7 and threatened to destabilize health insurance marketplaces by keeping billions of dollars from insurers.

The U.S. House of Representatives voted to repeal the 2.3 percent medical device tax that was implemented as part of the Affordable Care Act. The House voted 283 to 132, with 57 Democrats joining Republicans.

A new report co-commissioned by Politico and the Harvard T.H. Chan School of Public Health, delved deeper into Americans’ outlook regarding the Trump administration’s policies to address prescription drug prices. Though President Donald Trump has called this one of his “greatest priorities,” poll numbers show the country is skeptical.

A group of doctors filed suit against health insurance company Anthem for its pay practices over emergency room (ER) care.

The Trump administration is taking a wide approach in its efforts to lower drug prices—even considering importing drugs from abroad. 

The Office of Management and Budget (OMB) is reviewing a rule to unlock roughly $10 billion in payments for Affordable Care Act (ACA) insurance providers.

The Medicare bidding process is hurting patients, according to a new study from the Pacific Research Institute.